Big raise, same playbook
Norwest's 18th vehicle totals $4 billion, and the firm says it will unveil the news on Thursday. The fresh capital lifts assets under management to $18 billion, which includes this fund. That is a notable jump from its 2024 raise of $3 billion.
The 65-year-old firm has backed names like Uber Technologies Inc. and Spotify Technology SA, but says size will not change its pace. Amid bigger checks flooding into artificial intelligence, Norwest argues the advantage is a slower, more deliberate approach.
Where the firm is hunting
Senior managing partner Jeff Crowe said the firm will keep writing AI checks while looking harder at neglected corners of the market. He pointed to biopharma and consumer as areas with less investor crowding and more breathing room on price.
As AI valuations edge up, Norwest is trying to get in earlier. It has not backed leading frontier groups including OpenAI and Anthropic PBC, opting instead for companies applying AI in security and healthcare. Crowe added that the team is evaluating newcomers building open weight models, firms focused on AI inference, and data providers tied to fields like robotics. "We're really pushing hard to invest early in these opportunities, as opposed to the mega-mega-rounds that you see other firms doing," he said.
Smart investors blend time tested judgment with new tools to find an edge. We're hosting our first ever investor livestream on 11/17 to show you how to use ChatGPT and Claude to invest like a pro, hosted by Briefs Finance CEO Jaspreet Singh. Save your seat.
Structure, scale, and recent outcomes
Unlike many venture shops, Norwest's teams tap a single capital pool for both early- and late-stage deals, including growth equity buyouts. The firm counts 283 active portfolio companies, split into 200 on the venture side and 83 in growth equity.
The list spans AI and beyond. Vast Data Inc. carries a $30 billion valuation, while Vuori Inc. represents consumer exposure with unicorn status. Since its prior fundraise, Norwest notched multiple multi-billion-dollar outcomes: IPOs by Omada Health Inc. and India's Swiggy Ltd., plus Ouro Medicines being acquired in Gilead Sciences Inc.'s $2.2 billion deal.
People, footprint, and why patience helps
Based in Menlo Park, California, the firm employs 175 people, including 20 partners, with operations in Israel and India alongside the US. Managing partner Jon Kossow said the exit window has been tight: "Liquidity has been challenged for the entire ecosystem." With Wells Fargo as the sole limited partner, he said Norwest faces less pressure to rush sales and can stay consistent.
The bottom line: a larger war chest, one LP, and a single-pool structure give Norwest room to pick its spots, from early AI to sectors others are skipping. For your portfolio, that mix can shape which private names scale up to the public markets and when they get there.
Exploring emerging tools quietly can help investors sharpen decisions over the long term. On 11/17, our CEO Jaspreet Singh goes live for our first ever investor livestream on how to use ChatGPT and Claude to invest like a pro. Register to join him.
